Symyx Technologies has announced the launch of the Symyx Contract Development and Manufacturing Organisation (CDMO). The Symyx CDMO (www.symyx.com/CDMO) helps biopharmaceutical companies move promising drug candidates to clinical trials faster and more reliably with integrated formulation development and preclinical and CGMP fill/finish manufacturing. With expertise in preformulation development, formulation optimisation and stability, and analytical method development, the Symyx CDMO enables faster development of highly optimised and robust drug formulations, so that clinical trials test the efficacy of drug candidates, not the limitations of the formulation. In addition, the Symyx CDMO offers full service fill/finish execution for delivering drug products manufactured under CGMP conditions while maintaining the integrity of drug substances.
Symyx Technologies has announced the launch of the Symyx Contract Development and Manufacturing Organisation (CDMO). The Symyx CDMO (
Visit
the Laboratory News archive